FDA Adverse Event Malfunction Summary report: N

ACCESS® 2 IMMUNOASSAY CLINICAL SYSTEM

MDR report key: 2110562 · Received June 1, 2011

Report

Report Number
2122870-2011-01637
Event Type
Malfunction
Date Received
June 1, 2011
Date of Event
May 2, 2011
Report Date
May 4, 2011
Manufacturer
BECKMAN COULTER, INC.
Product Code
MMI
PMA / PMN Number
K922823/A007
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLES WERE COLLECTED IN GREINER VACUETTE 7ML TUBES, AND WERE SPUN FOR 10 MINUTES AT 3750GS AT ROOM TEMPERATURE. QC RUN IMMEDIATELY AFTER THE EVENT RECOVERED OUTSIDE THE ESTABLISHED RANGES. REPEATED QC CONTINUED TO FAIL. ACCUTNI WAS RECALIBRATED, AND QC THEN RECOVERED WITHIN THE ESTABLISHED RANGES. SYSTEM CHECK DATA, FROM BEFORE AND AFTER THE EVENT, WAS WITHIN THE SPECIFICATIONS. SERVICE WAS DISPATCHED TO VERIFY THE SYSTEM. HIGH SENSITIVITY SYSTEM CHECK WAS PERFORMED TWICE, RECOVERING WITHIN BECKMAN SPECIFICATIONS BOTH TIMES. PRECISION RUN ALSO WAS PERFORMED, PASSING WITHIN BECKMAN SPECIFICATIONS. ROOT CAUSE FOR THIS EVENT WAS UNDETERMINED.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER, INC. (BCI) IN REGARDS TO ERRONEOUSLY ELEVATED TROPONIN (ACCUTNI) RESULTS WITHIN THE RISK STRATIFICATION RANGE GENERATED BY ACCESS 2 IMMUNOASSAY SYSTEM FOR TWO PATIENTS. THE RESULTS WERE REPORTED OUT OF THE LABORATORY, BUT THE DOCTOR DID NOT BELIEVE THE RESULTS AND CONTACTED THE CUSTOMER. SUBSEQUENT TESTING AFTER RECALIBRATION PRODUCED RESULTS WITHIN THE NORMAL REFERENCE RANGE. THE RESULTS ARE SHOWN. THE CUSTOMER STATED THERE WAS NO DEATH OR INJURY TO PATIENT REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED TO OR CONNECTED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS® 2 IMMUNOASSAY CLINICAL SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER MMI BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1